公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，四川久远银海软件股份有限公司（以下简 称"公司"）将参加由四川省上市公司协会、深圳市全景网络有限公司联合举办的 "四川辖区2025年投资者网上集体接待日及半年度报告业绩说明会"活动，现将相 关事项公告如下： 本 次 活 动 将 采 用 网 络 远 程 的 方 式 举 行 ， 投 资 者 可 登 录 " 全 景 路 演 " （https://rs.p5w.net）参与本次互动交流，活动时间为2025年9月12日（周五） 14:00—17:00。公司董事长兼总经理连春华先生、财务总监兼董事会秘书杨成文先 生将在线就公司2025年半年度业绩、公司治理、发展战略、经营状况和可持续发展 等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告。 四川久远银海软件股份有限公司董事会 证券代码：002777 证券简称：久远银海 公告编号：2025-031 四川久远银海软件股份有限公司 关于参加四川辖区2025年投资者网上集体接待日及半年度报告 业绩说明会活动的公告 二〇二五年 ...

Core Viewpoint - The company, Jiuyuan Yinhai, is a strategic partner of Alibaba, collaborating in areas such as digital governance and smart city initiatives [1] Group 1 - The company plans to increase research and deployment of its "Wen Yu" large model [1] - There will be a focus on enhancing business and technical collaboration with Alibaba and other ecosystem partners [1] - The company aims to explore deeper cooperation in areas like AI computing power adaptation and innovation in AI industry scenarios [1]

Summary of Jiuyuan Yinhai Conference Call Company Overview - **Company**: Jiuyuan Yinhai - **Industry**: Information Technology and Healthcare Services Key Points and Arguments Industry and Market Dynamics - Jiuyuan Yinhai benefits from the construction of information systems in public welfare sectors despite fiscal tightening, supported by special bonds and fiscal assistance [2][3] - The company has seen a year-on-year increase of approximately 5% in signed and pending orders in healthcare, medical insurance, digital governance, and smart city sectors [2][4] Financial Performance - In the first half of 2025, Jiuyuan Yinhai's revenue grew by 11% year-on-year, with net profit attributable to shareholders increasing by 160% [3][11] - Cash flow from operating activities rose by about 35% compared to the same period last year, indicating strong performance in the public welfare information sector [3] Growth Areas - Significant growth in the medical insurance business, with a year-on-year increase of 30%-35% to approximately 180 million yuan, and smart city business revenue surged nearly 400% due to large project completions and new demands from the national medical insurance information platform [5][11] - The company is actively expanding into data elements and AI healthcare, indicating future growth potential [4][12] Future Outlook - The second half of the year is critical for revenue confirmation, with many project verifications concentrated in this period. The company expects strong performance by year-end due to improved government payment capabilities and smoother local government operations [6][13] - The 14th Five-Year Plan is concluding, and the 15th Five-Year Plan is set to start, with expectations for more targeted policies and information construction directions in the healthcare and human resources sectors [7][14] AI and Data Integration - Jiuyuan Yinhai is fully engaged in AI, particularly in core medical insurance, regulation, payment methods, and services, aiming to enhance competitiveness in the healthcare sector [9][10] - The company has established an AI evaluation and validation capability system to support its core medical AI capabilities [10] Project Management and Efficiency - The company has reduced its workforce from approximately 4,800 to below 4,000 through refined management, enhancing performance and per capita productivity [5][17] - Internal information technology improvements and modular application development are being utilized to increase efficiency and reduce reliance on personnel [18][19] Government Support and Policy Impact - The issuance of special bonds is expected to increase, with local governments likely to boost spending on public welfare projects, including information construction [13][20] - The national emphasis on high-quality construction and standardization in information technology is anticipated to benefit companies like Jiuyuan Yinhai in securing new projects and managing costs effectively [20] Pilot Projects and Innovations - The company is expanding pilot projects in Tianjin and other cities, focusing on data services for commercial insurance and real estate sectors, which have garnered positive feedback from local governments [15][16] Additional Important Insights - The company is preparing for the integration of data elements on a national scale, with early-stage pilot projects showing promise for future applications [8][14] - The involvement of major internet companies in the Beijing model for medical insurance services is expected to accelerate the development of data elements [8]

Core Viewpoint - JiuYuan YinHai's stock price has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 16.23%, indicating volatility in market performance [1] Financial Performance - For the first half of 2025, JiuYuan YinHai reported revenue of 439 million yuan, representing a year-on-year growth of 11.33% [2] - The net profit attributable to shareholders for the same period was approximately 29.95 million yuan, showing a significant increase of 166.63% year-on-year [2] Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 5.68% to 54,400, while the average number of circulating shares per person increased by 6.02% to 7,433 shares [2] - The company has distributed a total of 472 million yuan in dividends since its A-share listing, with 151 million yuan distributed over the past three years [3] Major Shareholders - As of June 30, 2025, Hong Kong Central Clearing Limited is the third-largest circulating shareholder, increasing its holdings by 910,200 shares to 4.6232 million shares [3] - Southern CSI 1000 ETF is the fifth-largest circulating shareholder, increasing its holdings by 489,700 shares to 2.6339 million shares [3] - E-Fonda New Normal Mixed Fund is a new entrant among the top ten circulating shareholders, holding 2.2 million shares [3]

Group 1 - The core viewpoint of the news is that Jiuyuan Yinhai's stock has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 16.23% [1] - As of June 30, 2025, Jiuyuan Yinhai reported a revenue of 439 million yuan, representing a year-on-year growth of 11.33%, and a net profit of approximately 29.95 million yuan, which is a significant increase of 166.63% compared to the previous year [2] - The company has distributed a total of 472 million yuan in dividends since its A-share listing, with 151 million yuan distributed in the last three years [3] Group 2 - Jiuyuan Yinhai's main business segments include operation and maintenance services (49.40%), software (34.76%), and system integration (15.60%) [1] - As of June 30, 2025, the number of Jiuyuan Yinhai's shareholders decreased by 5.68% to 54,400, while the average number of circulating shares per person increased by 6.02% to 7,433 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 910,200 shares, and new shareholder E Fund New Normal Mixed Fund, which holds 2.2 million shares [3]

Core Viewpoint - The company is actively developing its self-researched "Yinhai Wenyu" large model to cater to the needs of deep reasoning and content generation in various sectors, including healthcare, digital governance, and smart cities [2] Group 1: Healthcare Innovations - The company has developed an intelligent system named "Xingjie" aimed at hospitals, providing services such as intelligent triage, appointment scheduling, pre-consultation, patient accompaniment, and report interpretation [2] - For clinics, the company has introduced "Xingling," which offers intelligent pre-consultation, a medical encyclopedia service, and assists doctors with diagnostic support and rational medication [2] - These healthcare solutions are currently being promoted and applied in various regions [2] Group 2: Strategic Development - The company is committed to its innovation-driven development strategy while deepening its existing core business [2] - It is continuously exploring new fields and models within the industry to promote high-quality growth [2]

Core Viewpoint - JiuYuan YinHai (002777) reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit compared to the previous year, indicating a positive growth trajectory for the company. Financial Performance Summary - Total revenue for the first half of 2025 reached 439 million yuan, an increase of 11.33% year-on-year [1] - Net profit attributable to shareholders was 29.95 million yuan, up 160.02% year-on-year [1] - In Q2 2025, total revenue was 232 million yuan, reflecting a 16.32% increase year-on-year, while net profit for the quarter was 15.05 million yuan, a staggering increase of 1354.05% year-on-year [1] - Gross margin improved to 43.98%, up 12.16% year-on-year, and net margin rose to 6.59%, an increase of 525.74% year-on-year [1] - Total operating expenses (sales, management, and financial expenses) amounted to 107 million yuan, accounting for 24.25% of revenue, a decrease of 12.38% year-on-year [1] Cash Flow and Receivables - The net cash flow from operating activities increased by 34.79%, attributed to a reduction in cash payments for goods and services compared to the previous period [2] - Accounts receivable represented a significant portion of the company's financials, with accounts receivable to net profit ratio reaching 607.91% [1][6] Investment and Return Metrics - The company's return on invested capital (ROIC) for the previous year was 4.46%, indicating moderate capital efficiency [4] - The average expected earnings per share for 2025 is projected at 0.26 yuan, with anticipated total earnings of 105 million yuan [4] Fund Holdings - The largest fund holding JiuYuan YinHai is the Golden Eagle Medical Health Industry A fund, which holds 992,600 shares and has shown a significant increase in value over the past year [5]

Core Viewpoint - JiuYuan YinHai (002777) reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit compared to the previous year [1][2]. Financial Performance Summary - Total revenue for the first half of 2025 reached 439 million yuan, an increase of 11.33% year-on-year [1]. - Net profit attributable to shareholders was 29.95 million yuan, up 160.02% year-on-year [1]. - The second quarter alone saw total revenue of 232 million yuan, a 16.32% increase year-on-year, and net profit of 15.05 million yuan, a staggering increase of 1354.05% [1]. - Gross margin improved to 43.98%, up 12.16% year-on-year, while net margin rose to 6.59%, reflecting a 525.74% increase [1]. - The company's total expenses (sales, management, and financial) amounted to 107 million yuan, accounting for 24.25% of revenue, a decrease of 12.38% year-on-year [1]. Key Financial Metrics - Earnings per share (EPS) increased to 0.07 yuan, a rise of 133.33% year-on-year [1]. - Operating cash flow per share improved to -0.17 yuan, a 34.79% increase year-on-year [1]. - The company's receivables were notably high, with accounts receivable reaching 607.91% of net profit [1][3]. Changes in Financial Items - Cash and cash equivalents decreased by 51.79% due to increased time deposits and dividend payments [2]. - Inventory increased by 37.74% as a result of expanded business operations [2]. - Financial expenses rose by 43.58% due to decreased interest income from bank deposits [2]. - The total profit increased by 383.23%, driven by improved project gross margins [2]. Investment Insights - The company’s return on invested capital (ROIC) was 4.46%, indicating a relatively weak capital return compared to its historical median of 15.64% [3]. - Analysts expect the company's performance for 2025 to reach 105 million yuan, with an average EPS forecast of 0.26 yuan [3]. Fund Holdings - The largest fund holding JiuYuan YinHai is the Golden Eagle Medical Health Industry A fund, which has recently entered the top ten holdings with 992,600 shares [4].

Core Insights - The stock price of Jiuyuan Yinhai (002777) closed at 20.89 yuan on August 25, 2025, with a slight decline of 0.05% [1] - The company reported a total revenue of 439 million yuan for the first half of 2025, representing a year-on-year growth of 11.33% [1] - Net profit attributable to shareholders reached 29.95 million yuan, showing a significant increase of 160.02% year-on-year [1] - The company has a current ratio of 2.459 and a quick ratio of 2.011, indicating strong liquidity [1] Financial Performance - Jiuyuan Yinhai's operating revenue for the first half of 2025 was 439 million yuan, up 11.33% compared to the previous year [1] - The net profit attributable to shareholders was 29.95 million yuan, which is a 160.02% increase year-on-year [1] - The company's non-recurring net profit was 21.44 million yuan, reflecting a substantial growth of 250.12% year-on-year [1] - The asset-liability ratio stands at 31.39%, indicating a relatively low level of debt [1] Company Overview - Jiuyuan Yinhai Software Co., Ltd. was established in 2008 and is based in Chengdu, primarily engaged in software and information technology services [2] - The company has a registered capital of 4.08 billion yuan and a paid-in capital of 1.78 billion yuan [1] - The legal representative of the company is Lian Chunhua [1] Investment and Intellectual Property - Jiuyuan Yinhai has made investments in 20 companies and participated in 5,000 bidding projects [2] - The company holds 62 trademark registrations and 38 patents, showcasing its commitment to intellectual property [2] - Additionally, Jiuyuan Yinhai possesses 6 administrative licenses [2]

Core Viewpoint - JiuYuanYinHai's stock price has slightly decreased, while the company shows strong growth in revenue and net profit, particularly in its smart city business [1] Company Performance - As of August 25, 2025, JiuYuanYinHai's stock price is 20.89 yuan, down 0.01 yuan or 0.05% from the previous trading day [1] - The company reported a revenue of 439 million yuan for the first half of 2025, representing a year-on-year increase of 11.33% [1] - The net profit attributable to shareholders reached 29.94 million yuan, marking a significant year-on-year growth of 160.02% [1] Business Segments - JiuYuanYinHai operates in three main sectors: healthcare insurance, digital government, and smart city services [1] - The smart city business has shown exceptional performance, with revenue soaring by 409.88% to 51.70 million yuan [1] Market Presence - The company conducts operations across 29 provinces and over 240 cities in China, serving 160,000 healthcare institutions and 700 million members of the public [1]